Therapeutic Areas/Infectious Disease
COVID-19
Accelerating the rapid launch of COVID-19 vaccine and treatment trials with confidence.
While the COVID-19 pandemic has transitioned to its endemic stage, the need for developing new vaccines, boosters and treatments continues. Get started with bold scientific thinking from the clinical and regulatory teams that supported more than 70 COVID-19 clinical trials and consulting projects since the start of the pandemic.
Our global team of experts are available to assist with clinical trial design, clinical trial conduct, and all the regulatory and safety support required to keep your clinical development programs on track. And we offer proven virtual or decentralized trial solutions to ease the burden of patient participation.
Developing a COVID-19 treatment or vaccine? Let’s Talk.
+0
COVID-19 Clinical Trials and Consulting Projects
+0
IND/CTAs prepared
0%
for COVID-19 Vaccines
Supporting COVID-19 Vaccine, Diagnostic, and Treatment Programs
- Study Design and Methodology that works
- Development of regulatory strategy, expedited pathways, and regulatory agency interactions
- Clinical program planning, inclusive of statistical planning and analysis
- Agile patient recruitment strategies to support virtual trial and hybrid approaches
- Marketing Application Preparation and Publishing
- Post-Market Pharmacovigilance Ensure Safety
Scientific Knowledge across a Broad Range of COVID-19 Therapies
COVID-19 Prevention
- Antiseptic Nasal Sprays
Vaccines- DNA
Vaccines- mRNA
Vaccines- Peptide
And more...
COVID-19 Treatments
- Anti-Inflammatories
Anti-virals
Cannabinoids
Monoclonal Antibodies
And more...
"We thank the entire Veristat team, who has worked so diligently. We are gratified to know that the efforts and commitment of Verisat has resulted in an approved vaccine to advance protection against the virus.”